Description
Study will examine safety and efficacy of the investigational device, the Spiration Valve System, in treating patients with prolonged (more than 5 days) air leaks in the lungs when compared to standard medical management such as chest tube or surgical treatment.
Moreover, patients with prolonged air leak are usually poor candidates for surgical intervention and have very few treatment options.
Moreover, patients with prolonged air leak are usually poor candidates for surgical intervention and have very few treatment options.
Principal Investigator
Recruitment Information
Please see study flyer.
- Study Flyer (PDF)
Funder
Spiration, Inc.